Numerous vaccine clinics have been held at MH and WCV. Counting all residents who got vaccinated at MH, WCV and elsewhere, we know that 97% of WCV residents have been vaccinated, along with 97.5% of residents in Skilled Nursing and 100% of residents in Personal Care.
COVID-19 Vaccine Required for All MHC Staff Members
On September 13, 2021, MHC announced its decision to require all staff, at MH and WCV, to have received both doses of the Pfizer or Moderna vaccine, or the single dose Johnson & Johnson vaccine by November 30, 2021, against COVID-19 as a condition of employment unless they have an approved religious or medical exemption. Currently, all staff members are fully vaccinated against COVID-19, with the exception of a small number who have approved religious or medical exemptions.
Booster Information for MHC Residents and Staff
Thank you for everything you do to protect yourself and others from getting COVID-19.
If you took the important step of getting vaccinated, you may be eligible for a booster shot to stay protected against COVID-19.
Mennonite Home Communities has provided opportunities for residents and staff members to obtain the COVID-19 vaccinations free of charge.
We understand you may have questions about the vaccine and the booster shot. It’s best to discuss your questions with your doctor.
COVID-19 vaccines are an important tool to help stop the virus. However, even after vaccination, everyone will need to continue following the PPE and social distancing requirements that keep everyone safe.
Residents should ask the staff in their area if they have any questions. Staff should contact Human Resources with any questions.
Thank you again for all you are doing to stay safe.
Vaccine Information for MH Residents and Family Members
Vaccine information was communicated to MH residents and family members. The letter can be found here. Additional resident communication is available below.
Are the COVID-19 vaccines safe?
- Safety is the most important priority in vaccine approval
- Most adverse side effects occur within 6 weeks of vaccine administration, and the FDA has required 8 weeks of safety monitoring
- FDA advises a minimum of 3,000 participants to assess safety. The current phase 3 trials have 30,000 to 50,000 participants. This really demonstrates how safety is a top priority for the FDA and the medical community.
Why should we trust the COVID-19 vaccine?
- The FDA using the same standards that it has for decades
- There are no steps being “skipped”
- Data from the vaccine trials is being rigorously reviewed by independent experts
For more information please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html